Boston Scientific gets Canadian approval

Interventional device developer Boston Scientific of Natick, MA, has received a license for the sale of its Carotid Wallstent Monorail Endoprosthesis from Health Canada’s Therapeutic Products Directorate.

The firm said it received a license for the use of all stent sizes of the Carotid Wallstent system, and that it plans to launch the product immediately in Canada.

By staff writers
February 19, 2004

Related Reading

Boston Scientific expands Minnesota operations, February 18, 2004

Boston Scientific posts final 2003 results, February 2, 2004

Boston Scientific gets French reimbursement for Taxus, January 29, 2004

Boston Scientific shows uptick in preliminary 2003 results, January 14, 2004

Boston Scientific, NitroMed extend collaboration, January 8, 2004

Copyright © 2004

Page 1 of 180
Next Page